Vireo Growth (VREOF) Short-term Investments (2020 - 2026)
Vireo Growth (VREOF) reported Short-term Investments of $15.4 million for Q1 2026, up 779.04% on a YoY basis from $1.8 million in Q1 2025, and down 24.14% sequentially from $20.3 million in Q4 2025.
Vireo Growth (VREOF) Short-term Investments (2020 - 2026) Analysis & Trends
Vireo Growth (VREOF) has 5 years of Short-term Investments data on file, last reported at $15.4 million in Q1 2026.
- For the quarter ending Q1 2026, Short-term Investments rose 779.04% year-over-year to $15.4 million; the trailing twelve-month figure through Mar 2026 stood at $15.4 million (up 779.04% YoY), and the FY2025 full-year result was $20.3 million, up 793.89% from the prior year.
- Short-term Investments eased to $15.4 million in Q1 2026, from $20.3 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $20.3 million in Q4 2025 to a low of $1.0 million in Q3 2025.
- A 4-year average of $6.3 million and a median of $1.9 million in 2023 frame the typical range for Short-term Investments.
- Across the five-year window, Short-term Investments grew 17.22% in 2024 and soared 793.89% in 2025, its largest moves.
- Tracing VREOF's Short-term Investments over 4 years: stood at $1.9 million in 2023, then gained by 17.22% to $2.3 million in 2024, then soared by 793.89% to $20.3 million in 2025, then decreased by 24.14% to $15.4 million in 2026.
- Business Quant data shows VREOF's Short-term Investments at $15.4 million in Q1 2026, $20.3 million in Q4 2025, and $1.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.40 Mn |
| Dec 31, 2025 | 20.30 Mn |
| Sep 30, 2025 | 1.01 Mn |
| Jun 30, 2025 | 1.27 Mn |
| Mar 31, 2025 | 1.75 Mn |
| Dec 31, 2024 | 2.27 Mn |
| Dec 31, 2023 | 1.94 Mn |
| Dec 31, 2020 | 1.59 Mn |